Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics

Y Kanai - Pharmacology & therapeutics, 2022 - Elsevier
Cancer cells require a massive supply of nutrients, including sugars and amino acids—the
upregulation of transporters for each nutrient contributes to meet the demand. Distinct from …

Amino acid transporters revisited: New views in health and disease

P Kandasamy, G Gyimesi, Y Kanai… - Trends in biochemical …, 2018 - cell.com
Amino acid transporters (AATs) are membrane-bound transport proteins that mediate
transfer of amino acids into and out of cells or cellular organelles. AATs have diverse …

Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc

Y Lee, P Wiriyasermkul, C Jin, L Quan… - Nature structural & …, 2019 - nature.com
The L-type amino acid transporter 1 (LAT1 or SLC7A5) transports large neutral amino acids
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …

Tryptophan and its metabolites in normal physiology and cancer etiology

L Perez‐Castro, R Garcia, N Venkateswaran… - The FEBS …, 2023 - Wiley Online Library
Within the growing field of amino acid metabolism, tryptophan (Trp) catabolism is an area of
increasing interest. Trp is essential for protein synthesis, and its metabolism gives rise to …

α‐Emitting cancer therapy using 211At‐AAMT targeting LAT1

K Kaneda‐Nakashima, ZJ Zhang, Y Manabe… - Cancer …, 2021 - Wiley Online Library
Abstract α‐Methyl‐l‐tyrosine (AMT) has a high affinity for the cancer‐specific l‐type amino
acid transporter 1 (LAT1). Therefore, we established an anti‐cancer therapy, with 211At …

[HTML][HTML] Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment

K Hayashi, N Anzai - World journal of gastrointestinal oncology, 2017 - ncbi.nlm.nih.gov
L-type amino acid transporters (LATs) mainly assist the uptake of neutral amino acids into
cells. Four LATs (LAT1, LAT2, LAT3 and LAT4) have so far been identified. LAT1 (SLC7A5) …

[HTML][HTML] Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)

P Kongpracha, S Nagamori, P Wiriyasermkul… - Journal of …, 2017 - Elsevier
L-type amino acid transporter 1 (LAT1) is known as a cancer-type amino acid transporter. In
cancer cells, LAT1 is responsible for the cellular uptake of many essential amino acids …

[HTML][HTML] Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice

T Watabe, K Kaneda-Nakashima, Y Shirakami, Y Liu… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Phenylalanine derivatives, which target tumors especially through L-type amino acid
transporter-1 (LAT1), have elicited considerable attention. In this study, we evaluated the …

Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease

K Waløen, R Kleppe, A Martinez… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: The ancient and ubiquitous monoamine signalling molecules serotonin,
dopamine, norepinephrine, and epinephrine are involved in multiple physiological functions …

18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET

T Watabe, H Ikeda, S Nagamori… - European journal of …, 2017 - Springer
Purpose The purpose of this study was to evaluate the usefulness of L-4-borono-2-18 F-
fluoro-phenylalanine (18 F-FBPA) as a tumor-specific probe, in comparison to 18 F-FDG and …